- ►bcell.org [PDF] PE MacDonald, W El-kholy, MJ Riedel, AMF … - Diabetes, 2002 - Am Diabetes Assoc The physiological effects of glucagon-like peptide-1 (GLP-1) are of immense
interest because of the potential clinical relevance of this peptide. Produced
in intestinal L-cells through posttranslational processing of the ... Cited by 95 - Related articles - BL Direct - All 4 versions
NS Track, RS McLeod, AV Mee - Canadian journal of physiology and pharmacology, 1980 - ncbi.nlm.nih.gov Circulating human pancreatic polypeptide (HPP) was studied in 16 human subjects
during two 24-h test periods, one fasting and another eating meals at 0830,
1230, and 1730. In six subjects the tests were repeated with propantheline ... Cited by 37 - Related articles
- ►endojournals.org X Wang, J Zhou, ME Doyle, JM Egan - Endocrinology, 2001 - Endocrine Soc Glucagon-like peptide-1 (GLP-1) enhances insulin secretion and synthesis. It
also regulates the insulin, glucokinase, and GLUT2 genes. It mediates increases
in glucose-stimulated insulin secretion by activating adenylyl cyclase and ... Cited by 71 - Related articles - BL Direct - All 3 versions
PE MacDonald, AMF Salapatek, MB Wheeler - Diabetes, 2002 - Am Diabetes Assoc Glucagon-like peptide-1 (GLP-1) acts through its G-protein-coupled receptor to
enhance glucose-stimulated insulin secretion from pancreatic β-cells. This is
believed to result from modulation of at least two ion channels: ... Cited by 40 - Related articles - BL Direct - All 3 versions
A Le Quellec, A Kervran, P Blache, AJ Ciurana … - Journal of Clinical Endocrinology & Metabolism, 1992 - Endocrine Soc ABSTRACT. The biological specificity of oxyntomodulin to- ward the gastric
mucosa results from its C-terminal octapeptide. A RIA using a specific antibody
raised against this region per- mitted quantification of the whole set of ... Cited by 43 - Related articles - All 3 versions
- ►eje-online.org [PDF] M Peracchi, R Tagliabue, M Quatrini, E … - European Journal of Endocrinology, 1999 - EFES Objective: Intravenously administered secretin stimulates pancreatic polypeptide
(PP) release in patients with endocrine enteropancreatic tumors, but data in
patients with nontumorous disorders are controversial. Therefore, we aimed ... Cited by 9 - Related articles - BL Direct - All 7 versions
S Fujimoto, A Inui, N Kiyota, W Seki, K … - Biological Psychiatry, 1997 - Elsevier E Phillip, KM Pirke, MB Kellner and JC Krieg, Disturbed cholecystokinin
secretion in patients with eating disorders, Life Sci 48 (1991), pp.
2443–2450. ... This work was supported in part by Grants-in-Aid for ... Cited by 31 - Related articles - All 9 versions
HC Fehmann, J JIANG, J Schweinfurth, MB … - Peptides(New York, NY. 1980), 1994 - cat.inist.fr Stable expression of the rat GLP-I receptor in CHO cells: activation and binding
characteristics utilizing GLP-I (7-36)-amide, oxyntomodulin, exendin-4, and ... Cited by 34 - Related articles - All 2 versions
BP Bullock, RS Heller, JF Habener - Endocrinology, 1996 - Endocrine Soc Page 1. 0013.7227/96/$03.00/O Endocrmology Copynght 0 1996 by The Endocrine
Society Vol. 137, No. 7 Printed LIZ USA Tissue Distribution ... Cited by 143 - Related articles - BL Direct - All 3 versions
X Fu-Cheng, Y Anini, J Chariot, N Castex, JP … - Pflügers Archiv European Journal of Physiology, 1997 - Springer &p.1:Abstract Peptide YY (PYY) release in anaesthetized rats was studied during
the 2 h following the intraduode- nal administration of a semi-liquid meal of 21
kJ. Surgi- cal and pharmacological manipulations were performed in order to ... Cited by 40 - Related articles - BL Direct - All 4 versions
